In this study of men’s ability to adjust perceived risk of prostate-cancer mortality based on PSA risk reduction data, we found that how risk data are presented to patients can have a profound effect on their ability to interpret and apply the data accurately. The gene discussed is KLK3; the disease is prostate carcinoma.